RWM
TXG icon

Rialto Wealth Management’s 10x Genomics TXG Stock Holding History

Rialto Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3K Hold
60
– – ﹤0.01% 1071
2026
Q1 		$1.27K Hold
60
– – ﹤0.01% 1021
2025
Q4 		$979 Hold
60
– – ﹤0.01% 1007
2025
Q3 		$702 Hold
60
– – ﹤0.01% 1075
2025
Q2 		$695 Buy
+60
New +$547 ﹤0.01% 992

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rialto Wealth Management's TXG Position: Q2 2026 in Review

Rialto Wealth Management held its 10x Genomics (TXG) position steady in Q2 2026 at 60 shares worth $2.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Rialto Wealth Management first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Rialto Wealth Management held 60 shares of 10x Genomics worth $2.3K as of Q2 2026.
  • Rialto Wealth Management left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1071 holding.
  • Rialto Wealth Management first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.